131 related articles for article (PubMed ID: 29884419)
1. Predictors of oropharyngeal cancer survival in Europe.
Anantharaman D; Billot A; Waterboer T; Gheit T; Abedi-Ardekani B; Lagiou P; Lagiou A; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Polesel J; Simonato L; Alemany L; Mena Cervigon M; Macfarlane TV; Znaor A; Thomson PJ; Robinson M; Canova C; Conway DI; Wright S; Healy CM; Toner ME; Pawlita M; Tommasino M; Brennan P
Oral Oncol; 2018 Jun; 81():89-94. PubMed ID: 29884419
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
[TBL] [Abstract][Full Text] [Related]
3. HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status.
Anderson KS; Dahlstrom KR; Cheng JN; Alam R; Li G; Wei Q; Gross ND; Chowell D; Posner M; Sturgis EM
Oral Oncol; 2015 Jul; 51(7):662-7. PubMed ID: 25957822
[TBL] [Abstract][Full Text] [Related]
4. Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of Human Papillomavirus is attenuated among older patients: Analysis of the National Cancer Database.
Rettig EM; Zaidi M; Faraji F; Eisele DW; El Asmar M; Fung N; D'Souza G; Fakhry C
Oral Oncol; 2018 Aug; 83():147-153. PubMed ID: 30098771
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation within the human papillomavirus type 16 genome is associated with oropharyngeal cancer prognosis.
Lang Kuhs KA; Faden DL; Chen L; Smith DK; Pinheiro M; Wood CB; Davis S; Yeager M; Boland JF; Cullen M; Steinberg M; Bass S; Wang X; Liu P; Mehrad M; Tucker T; Lewis JS; Ferris RL; Mirabello L
Ann Oncol; 2022 Jun; 33(6):638-648. PubMed ID: 35306154
[TBL] [Abstract][Full Text] [Related]
6. Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium.
Robbins HA; Ferreiro-Iglesias A; Waterboer T; Brenner N; Nygard M; Bender N; Schroeder L; Hildesheim A; Pawlita M; D'Souza G; Visvanathan K; Langseth H; Schlecht NF; Tinker LF; Agalliu I; Wassertheil-Smoller S; Ness-Jensen E; Hveem K; Grioni S; Kaaks R; Sánchez MJ; Weiderpass E; Giles GG; Milne RL; Cai Q; Blot WJ; Zheng W; Weinstein SJ; Albanes D; Huang WY; Freedman ND; Kreimer AR; Johansson M; Brennan P
J Clin Oncol; 2022 Nov; 40(31):3613-3622. PubMed ID: 35700419
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypes.
Varier I; Keeley BR; Krupar R; Patsias A; Dong J; Gupta N; Parasher AK; Genden EM; Miles BA; Teng M; Bakst RL; Gupta V; Misiukiewicz KJ; Chiao EY; Scheurer ME; Laban S; Zhang D; Ye F; Cui M; Demicco EG; Posner MR; Sikora AG
Head Neck; 2016 Sep; 38(9):1330-7. PubMed ID: 27080140
[TBL] [Abstract][Full Text] [Related]
8. Serum Antibodies to HPV16 Early Proteins Warrant Investigation as Potential Biomarkers for Risk Stratification and Recurrence of HPV-Associated Oropharyngeal Cancer.
Fakhry C; Qualliotine JR; Zhang Z; Agrawal N; Gaykalova DA; Bishop JA; Subramaniam RM; Koch WM; Chung CH; Eisele DW; Califano J; Viscidi RP
Cancer Prev Res (Phila); 2016 Feb; 9(2):135-41. PubMed ID: 26701665
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus (HPV) 16 antibodies at diagnosis of HPV-related oropharyngeal cancer and antibody trajectories after treatment.
Zhang Y; Waterboer T; Haddad RI; Miles BA; Wentz A; Gross ND; Fakhry C; Quon H; Lorch JH; Gourin CG; Clayburgh D; Misiukiewicz KJ; Richmon JD; Andersen PE; Posner MR; D'Souza G
Oral Oncol; 2017 Apr; 67():77-82. PubMed ID: 28351584
[TBL] [Abstract][Full Text] [Related]
10. Validation of the ICON-S staging for HPV-associated oropharyngeal carcinoma using a pre-defined treatment policy.
Porceddu SV; Milne R; Brown E; Bernard A; Rahbari R; Cartmill B; Foote M; McGrath M; Coward J; Panizza B
Oral Oncol; 2017 Mar; 66():81-86. PubMed ID: 28249652
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of human papillomavirus in oropharyngeal cancer is increasing regardless of sex or race, and the influence of sex and race on survival is modified by human papillomavirus tumor status.
Faraji F; Rettig EM; Tsai HL; El Asmar M; Fung N; Eisele DW; Fakhry C
Cancer; 2019 Mar; 125(5):761-769. PubMed ID: 30521092
[TBL] [Abstract][Full Text] [Related]
12. Combined effects of smoking and HPV16 in oropharyngeal cancer.
Anantharaman D; Muller DC; Lagiou P; Ahrens W; Holcátová I; Merletti F; Kjærheim K; Polesel J; Simonato L; Canova C; Castellsague X; Macfarlane TV; Znaor A; Thomson P; Robinson M; Conway DI; Healy CM; Tjønneland A; Westin U; Ekström J; Chang-Claude J; Kaaks R; Overvad K; Drogan D; Hallmans G; Laurell G; Bueno-de-Mesquita HB; Peeters PH; Agudo A; Larrañaga N; Travis RC; Palli D; Barricarte A; Trichopoulou A; George S; Trichopoulos D; Quirós JR; Grioni S; Sacerdote C; Navarro C; Sánchez MJ; Tumino R; Severi G; Boutron-Ruault MC; Clavel-Chapelon F; Panico S; Weiderpass E; Lund E; Gram IT; Riboli E; Pawlita M; Waterboer T; Kreimer AR; Johansson M; Brennan P
Int J Epidemiol; 2016 Jun; 45(3):752-61. PubMed ID: 27197530
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer.
Kreimer AR; Johansson M; Yanik EL; Katki HA; Check DP; Lang Kuhs KA; Willhauck-Fleckenstein M; Holzinger D; Hildesheim A; Pfeiffer R; Williams C; Freedman ND; Huang WY; Purdue MP; Michel A; Pawlita M; Brennan P; Waterboer T
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376197
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of non-HPV16 genotypes in oropharyngeal squamous cell carcinoma.
Mazul AL; Rodriguez-Ormaza N; Taylor JM; Desai DD; Brennan P; Anantharaman D; Gheit T; Tommasino M; Abedi-Ardekani B; Olshan AF; Zevallos JP
Oral Oncol; 2016 Oct; 61():98-103. PubMed ID: 27688111
[TBL] [Abstract][Full Text] [Related]
15. HPV driven squamous cell head and neck cancer of unknown primary is likely to be HPV driven squamous cell oropharyngeal cancer.
Schroeder L; Pring M; Ingarfield K; Pawlita M; Leary SD; Thomas SJ; Waylen A; Waterboer T; Ness AR
Oral Oncol; 2020 Aug; 107():104721. PubMed ID: 32361566
[TBL] [Abstract][Full Text] [Related]
16. Determination of Role of Type 16 Human Papillomavirus and Risk Factors in Assessing Oropharyngeal Cancer Survival.
Bhasin M; Singh HP; Singh P; Dhingra R; Kohli SA; Azad A
J Pharm Bioallied Sci; 2021 Nov; 13(Suppl 2):S1300-S1302. PubMed ID: 35017975
[TBL] [Abstract][Full Text] [Related]
17. Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.
Huang SH; Xu W; Waldron J; Siu L; Shen X; Tong L; Ringash J; Bayley A; Kim J; Hope A; Cho J; Giuliani M; Hansen A; Irish J; Gilbert R; Gullane P; Perez-Ordonez B; Weinreb I; Liu FF; O'Sullivan B
J Clin Oncol; 2015 Mar; 33(8):836-45. PubMed ID: 25667292
[TBL] [Abstract][Full Text] [Related]
18. Oropharyngeal cancer prognosis by tumour HPV status in France: The multicentric Papillophar study.
Lacau St Guily J; Rousseau A; Baujat B; Périé S; Schultz P; Barry B; Dufour X; Malard O; Pretet JL; Clavel C; Birembaut P; Franceschi S;
Oral Oncol; 2017 Apr; 67():29-36. PubMed ID: 28351578
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte telomere length predicts clinical outcomes of HPV-positive oropharyngeal cancer patients after definitive radiotherapy.
Luo X; Sturgis EM; Yang Z; Sun Y; Wei P; Liu Z; Wei Q; Li G
Carcinogenesis; 2019 Jul; 40(6):735-741. PubMed ID: 30721961
[TBL] [Abstract][Full Text] [Related]
20. Survival advantage in patients with human papillomavirus-driven oropharyngeal cancer and variation by demographic characteristics and serologic response: Findings from Head and Neck 5000.
Whitmarsh A; Pring M; Thomas SJ; Waylen A; Ness AR; Dudding T; Pawlita M; Brenner N; Waterboer T; Schroeder L
Cancer; 2021 Jul; 127(14):2442-2452. PubMed ID: 33721332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
